跳至主要内容
临床试验/NCT03513419
NCT03513419已完成不适用

The AMOR Method: Resilience Training for Parents of Children With Autism

Stanford University1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2018年5月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Change in Connor-Davidson Resilience Scale (CDRISC) from Baseline to week 8

研究概览

简要总结

We will evaluate whether a resilience training program which includes group and individual parent training will be effective in improving optimism and resiliency in parents of young children with autism spectrum disorders (ASD). By observing the level of parent optimism and resiliency before and after intervention, we will be able to determine whether the intervention is effective in improving parent resilience.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Parents eligible to participate include parents: a) English-speaking, b) of a child aged 4:0 to 10:11 years, c) with a previous diagnosis of ASD and evidence of current social impairment (SRS-2) and repetitive behaviors (RBS-R), and d) who are able to consistently participate in sessions. Given budgetary constraints, direct diagnostic testing will not be feasible. Instead, child diagnostic status will be confirmed through review of the child's medical record for evidence that the child previously met ADOS criteria for ASD and shows clinically significant social impairment at baseline (SRS-2 T>65).
  • •Parents who are not eligible to participate include parents: a) with severe psychiatric, genetic, or medical disorder among parents and/or children, b) taking psychiatric medication, and c) with elevated resilience scores at baseline (Total Score >80 on CD-RISC). The DSM-5 CCSM will be administered to parents to screen for parent mental illness. Any identified issues on the DSM-5 CCSM will be investigated further by the PI to rule out severe psychiatric disorders.

排除标准

  • •a) Severe psychiatric, genetic, or medical disorder among parents and/or children, b) parents taking psychiatric medication, and c) parents with elevated resilience scores at baseline (Total Score>80 on CD-RISC). The DSM-5 Cross Cutting Symptom Measure (DSM-5 CCSM) will be administered to parents to screen for parent mental illness. Any identified issues on the DSM-5 CCSM will be investigated further by the PI to rule out severe psychiatric disorders. These families will be referred for behavioral consultation (available in our clinic) and then be reconsidered for group participation.

研究组 & 干预措施

AMOR Method

Experimental

The AMOR Method: The parent resilience training involves a series of eight weekly 90-minute group sessions, as well as three individual sessions. Group session content includes training in mindfulness, grief and loss processing, acceptance and committed actions, optimistic thinking, and resilience through the use of didactic training, group discussions, and homework assignments. Individual session content will center on additional and individualized training in grief and loss processing, optimistic thinking, and maintaining resilience over time.

干预措施: The AMOR Method (Behavioral)

Wait List

No Intervention

Participants assigned to the waitlist will continue stable treatments and will be offered the opportunity to participate in the treatment after completion of the 8-week trial.

结局指标

主要结局

Change in Connor-Davidson Resilience Scale (CDRISC) from Baseline to week 8

时间窗: Baseline, week 8

No subscales, total score only, 25 items total, 0-4 Likert Score Range: 0-100 Low resilience score (PTSD \& grief populations) = 45 or lower; Average/Normal resilience score (general population) = 45-80; High Average/Elevated resilience score (yogi \& meditation teachers) = 81-100 Higher total scores reflect higher levels of resilience.

次要结局

  • Change in Life Orientation Test Revised (LOT-R) from Baseline to week 8(Baseline, week 8)
  • Change in Acceptance and Action Questionnaire-II (AAQ-II) from Baseline to week 8(Baseline, week 8)
  • Change in Mindful Attention Awareness Scale (MAAS) from Baseline to week 8(Baseline, week 8)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Grace Gengoux

Clinical Associate Professor

Stanford University

研究点 (1)

Loading locations...

相似试验